Schedule of Class H Warrant Agreements Issued by Cavit Sciences, Inc. to Original Investors

Summary

Cavit Sciences, Inc. issued Class H warrants to four original investors, allowing them to purchase company stock. In exchange, these investors permanently waived their anti-dilution rights for future stock issuances. The warrants are similar except for the holder's name, number of shares, exercise price, and term. This schedule summarizes the differences among the warrants, which are otherwise identical to the example provided in Exhibit 4.13.

EX-4.14 7 ex4-14.txt SCHEDULE OF DOCUMENTS Exhibit 4.14 SCHEDULE OF DOCUMENTS SIMILAR TO EXHIBIT 4.13 THAT HAVE BEEN OMITTED FROM THIS ANNUAL REPORT ON FORM 10-K (WITH AN EXPLANATION OF MATERIAL DETAILS IN WHICH SUCH OMITTED DOCUMENTS DIFFER FROM EXHIBIT 4.13). On October 26, 2007, Cavit Sciences, Inc. issued a series of Class H warrants to purchase Cavit common stock to four of its original investors in consideration for said four investors forever waiving their anti-dilution rights with respect to future issuances of Cavit common stock. Cavit has elected to omit from its exhibits to this Annual Report actual copies of some of warrants due to the voluminous and redundant nature of such additional warrants. While the majority of the language, terms and conditions of the various warrants are identical, the warrants differ in four areas: (i) name of warrant holders; (ii) number of shares of common stock covered by the warrants; (iii) exercise price of the warrants and (iv) term of the warrants. The following table explains the differences in the omitted warrants from the warrant attached to this Annual Report as Exhibit 4.13: Number of Name of Holder Shares Covered Exercise Price Term - -------------- -------------- -------------- ---- Raymond Bazley 100,000 $ .55 Sixty months Cortland Fund, LLC 100,000 $ .55 Margaret Smyth 100,000 $ .55 Sixty months Robert Hennen 13,334 $ .55 Sixty months